UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 74

Sortiert nach

The Key Differences between Human Papillomavirus-Positive and -Negative Head and Neck Cancers: Biological and Clinical Implications

Cancers, 2021-10, Vol.13 (20), p.5206

2021

Volltextzugriff (PDF)

Cancer exosomes induce tumor innervation

Nature communications, 2018-10, Vol.9 (1), p.4284-15, Article 4284

2018

Volltextzugriff (PDF)

HPV upregulates MARCHF8 ubiquitin ligase and inhibits apoptosis by degrading the death receptors in head and neck cancer

PLoS pathogens, 2023-03, Vol.19 (3), p.e1011171-e1011171

2023

Volltextzugriff (PDF)

Neoadjuvant nivolumab for patients with resectable HPV-positive and HPV-negative squamous cell carcinomas of the head and neck in the CheckMate 358 trial

Journal for immunotherapy of cancer, 2021-06, Vol.9 (6), p.e002568

2021

Volltextzugriff (PDF)

Immune microenvironment modulation unmasks therapeutic benefit of radiotherapy and checkpoint inhibition

Journal for immunotherapy of cancer, 2019-08, Vol.7 (1), p.216-21, Article 216

2019

Volltextzugriff (PDF)

Near-infrared photoimmunotherapy targeting human-EGFR in a mouse tumor model simulating current and future clinical trials

EBioMedicine, 2021-05, Vol.67, p.103345-103345, Article 103345

2021

Volltextzugriff (PDF)

Characterization of the Immune Response to PD-1 Blockade during Chemoradiotherapy for Head and Neck Squamous Cell Carcinoma

Cancers, 2022-05, Vol.14 (10), p.2499

2022

Volltextzugriff (PDF)

The PDZ Binding Motif of Human Papillomavirus Type 16 E6 Induces PTPN13 Loss, Which Allows Anchorage-Independent Growth and Synergizes with Ras for Invasive Growth

Journal of Virology, 2008-03, Vol.82 (5), p.2493-2500

2008

Volltextzugriff (PDF)

The multifarious roles of the chemokine CXCL14 in cancer progression and immune responses

Molecular carcinogenesis, 2020-07, Vol.59 (7), p.794-806

2020

Volltextzugriff (PDF)

Safety and Efficacy of Pembrolizumab With Chemoradiotherapy in Locally Advanced Head and Neck Squamous Cell Carcinoma: A Phase IB Study

Journal of clinical oncology, 2020-07, Vol.38 (21), p.2427-2437

2020

Volltextzugriff (PDF)

Assessment of Swallowing Function in Patients with Head and Neck Squamous Cell Carcinoma in High vs. Low Dose Cisplatin

Cancer investigation, 2023-12, Vol.41 (10), p.807-815

2023

Volltextzugriff (PDF)

Nanoparticle albumin-bound paclitaxel with cetuximab and carboplatin as first-line therapy for recurrent or metastatic head and neck cancer: A single-arm, multicenter, phase 2 trial

Oral oncology, 2021-04, Vol.115, p.105173-105173, Article 105173

2021

Volltextzugriff (PDF)

Topical superoxide dismutase in posttreatment fibrosis in patients with head and neck cancer

Head & neck, 2018-07, Vol.40 (7), p.1400-1405

2018

Volltextzugriff (PDF)

CXCL14 suppresses human papillomavirus-associated head and neck cancer through antigen-specific CD8 + T-cell responses by upregulating MHC-I expression

Oncogene, 2019-11, Vol.38 (46), p.7166-7180

2019

Volltextzugriff (PDF)

Radiation‐induced loss of cell surface CD47 enhances immune‐mediated clearance of human papillomavirus‐positive cancer

International journal of cancer, 2013-07, Vol.133 (1), p.120-129

2013

Volltextzugriff (PDF)

Prognostic Impact of Metastatic Site and Pattern in Patients with Metastatic Head and Neck Cancer

The Laryngoscope, 2021-06, Vol.131 (6), p.E1838-E1846

2021

Volltextzugriff (PDF)

Examining the relationship of immunotherapy and wound complications following flap reconstruction in patients with head and neck cancer

Head & neck, 2021-05, Vol.43 (5), p.1509-1520

2021

Volltextzugriff (PDF)

Phase II study of dichloroacetate, an inhibitor of pyruvate dehydrogenase, in combination with chemoradiotherapy for unresected, locally advanced head and neck squamous cell carcinoma

Investigational new drugs, 2022-06, Vol.40 (3), p.622-633

2022

Volltextzugriff (PDF)

Adverse event reporting in head and neck transoral robotic surgery: a MAUDE database study

Journal of robotic surgery, 2021-12, Vol.15 (6), p.899-904

2021

Volltextzugriff (PDF)

nab-Paclitaxel and cisplatin followed by cisplatin and radiation (Arm 1) and nab-paclitaxel followed by cetuximab and radiation (Arm 2) for locally advanced head and neck squamous-cell carcinoma: a multicenter, non-randomized phase 2 trial

Medical oncology (Northwood, London, England), 2021-04, Vol.38 (4), p.35-35, Article 35

2021

Volltextzugriff (PDF)

Oral Cavity Reconstruction Outcomes Using a Porcine Urinary Bladder Matrix: A Retrospective Case Series

Wounds (King of Prussia, Pa.), 2018-05, Vol.30 (5), p.131-137

2018

Volltextzugriff (PDF)

Impact of PET/CT on Staging and Treatment of Advanced Head and Neck Squamous Cell Carcinoma

Otolaryngology-head and neck surgery, 2019-02, Vol.160 (2), p.261-266

2019

Volltextzugriff (PDF)

Functional neuronal circuits promote disease progression in cancer

Science advances, 2023-05, Vol.9 (19), p.eade4443-eade4443

2023

Volltextzugriff (PDF)

Unresectable cutaneous squamous cell carcinoma of the forehead with MLH1 mutation showing dramatic response to Programmed Cell Death Protein 1 Inhibitor Therapy

Clinical skin cancer, 2016-01, Vol.1 (1), p.26-29

2016

Volltextzugriff (PDF)

1 – 25 von 74

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(67)
Mit Volltextzugriff
(65)

Publikationsform

Artikel
(73)
Reviews
(1)

Sprache

Englisch
(74)
Japanisch
(9)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

The Key Differences between Human Papillomavirus-Positive and -Negative Head and Neck Cancers: Biological and Clinical Implications

Cancer exosomes induce tumor innervation

HPV upregulates MARCHF8 ubiquitin ligase and inhibits apoptosis by degrading the death receptors in head and neck cancer

Neoadjuvant nivolumab for patients with resectable HPV-positive and HPV-negative squamous cell carcinomas of the head and neck in the CheckMate 358 trial

Immune microenvironment modulation unmasks therapeutic benefit of radiotherapy and checkpoint inhibition

Near-infrared photoimmunotherapy targeting human-EGFR in a mouse tumor model simulating current and future clinical trials

Characterization of the Immune Response to PD-1 Blockade during Chemoradiotherapy for Head and Neck Squamous Cell Carcinoma

The PDZ Binding Motif of Human Papillomavirus Type 16 E6 Induces PTPN13 Loss, Which Allows Anchorage-Independent Growth and Synergizes with Ras for Invasive Growth

The multifarious roles of the chemokine CXCL14 in cancer progression and immune responses

Nociceptor neurons affect cancer immunosurveillance

Safety and Efficacy of Pembrolizumab With Chemoradiotherapy in Locally Advanced Head and Neck Squamous Cell Carcinoma: A Phase IB Study

Assessment of Swallowing Function in Patients with Head and Neck Squamous Cell Carcinoma in High vs. Low Dose Cisplatin

Nanoparticle albumin-bound paclitaxel with cetuximab and carboplatin as first-line therapy for recurrent or metastatic head and neck cancer: A single-arm, multicenter, phase 2 trial

Topical superoxide dismutase in posttreatment fibrosis in patients with head and neck cancer

CXCL14 suppresses human papillomavirus-associated head and neck cancer through antigen-specific CD8 + T-cell responses by upregulating MHC-I expression

Radiation‐induced loss of cell surface CD47 enhances immune‐mediated clearance of human papillomavirus‐positive cancer

Prognostic Impact of Metastatic Site and Pattern in Patients with Metastatic Head and Neck Cancer

Examining the relationship of immunotherapy and wound complications following flap reconstruction in patients with head and neck cancer

Phase II study of dichloroacetate, an inhibitor of pyruvate dehydrogenase, in combination with chemoradiotherapy for unresected, locally advanced head and neck squamous cell carcinoma

Adverse event reporting in head and neck transoral robotic surgery: a MAUDE database study

nab-Paclitaxel and cisplatin followed by cisplatin and radiation (Arm 1) and nab-paclitaxel followed by cetuximab and radiation (Arm 2) for locally advanced head and neck squamous-cell carcinoma: a multicenter, non-randomized phase 2 trial

Oral Cavity Reconstruction Outcomes Using a Porcine Urinary Bladder Matrix: A Retrospective Case Series

Impact of PET/CT on Staging and Treatment of Advanced Head and Neck Squamous Cell Carcinoma

Functional neuronal circuits promote disease progression in cancer

Unresectable cutaneous squamous cell carcinoma of the forehead with MLH1 mutation showing dramatic response to Programmed Cell Death Protein 1 Inhibitor Therapy

Suchergebnisse filtern